{"id":34364,"date":"2009-10-28T13:14:38","date_gmt":"2009-10-28T17:14:38","guid":{"rendered":"http:\/\/www.pehub.com\/?p=53990"},"modified":"2009-10-28T13:14:38","modified_gmt":"2009-10-28T17:14:38","slug":"mytrus-raising-new-round","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/34364","title":{"rendered":"Mytrus Raising New Round"},"content":{"rendered":"<p><strong>Mytrus<\/strong>, a stealth-mode provider of clinical trials for pharmaceutical customers, has secured $1 million of a $3 million funding round, according to a regulatory filing. No investor information was disclosed by the Mill Valley, Calif.-based company.<\/p>\n<p><a href=\"http:\/\/sharethis.com\/item?&#038;wp=2.6.2&amp;publisher=cc2b1207-de99-4484-bf7a-c797973e9397&amp;title=Mytrus+Raising+New+Round&amp;url=http%3A%2F%2Fwww.pehub.com%2F53990%2Fmytrus-raising-new-round%2F\">ShareThis<\/a><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/sfBaiYKX8xBt2c_V79i_sCYr3nw\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/sfBaiYKX8xBt2c_V79i_sCYr3nw\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/sfBaiYKX8xBt2c_V79i_sCYr3nw\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/sfBaiYKX8xBt2c_V79i_sCYr3nw\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:dnMXMwOfBR0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=dnMXMwOfBR0\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=CCbYNDKDCj8:tCbQ6pQDZaU:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=CCbYNDKDCj8:tCbQ6pQDZaU:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=CCbYNDKDCj8:tCbQ6pQDZaU:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=l6gmwiTKsz0\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/pehub\/news\/all\/~4\/CCbYNDKDCj8\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mytrus, a stealth-mode provider of clinical trials for pharmaceutical customers, has secured $1 million of a $3 million funding round, according to a regulatory filing. No investor information was disclosed by the Mill Valley, Calif.-based company. ShareThis<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-34364","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/34364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=34364"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/34364\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=34364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=34364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=34364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}